Literature DB >> 15094386

Functional analysis of a dominant-negative DeltaETS TEL/ETV6 isoform.

Ko Sasaki1, Yuka Nakamura, Kazuhiro Maki, Kazuo Waga, Fumihiko Nakamura, Honoka Arai, Yoichi Imai, Hisamaru Hirai, Kinuko Mitani.   

Abstract

A transcriptional repressor TEL belongs to the ETS family transcription factors and acts as a tumor suppressor. We identified five alternatively spliced TEL isoforms generated possibly through exon skipping mechanisms, by using reverse transcriptase-polymerase chain reaction analysis. Among them, we examined molecular and biological functions of a DeltaETS-TEL isoform (TEL-f). This isoform abrogated specific DNA-binding capacity to and trans-repressional ability through the ETS-binding site. Regardless, it showed dominant-negative effects over wild-type-TEL (TEL-a)-mediated transcriptional repression partly through sequestration of TEL-a from nucleus to cytoplasm. Moreover, TEL-f dominantly interfered with TEL-a-mediated erythroid differentiation in MEL cells and growth suppression in NIH3T3 cells. Interestingly, TEL isoforms without the entire (Delta exons 6+7-TEL) or a part (Delta exon 7-TEL) of ETS domain were expressed more frequently in myelodysplastic syndrome-derived leukemia than in myelodysplastic syndrome before transformation. This observation suggests that accumulation of the dominant-negative DeltaETS-TEL molecules could be a related phenomenon to leukemic progression of myelodysplastic syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094386     DOI: 10.1016/j.bbrc.2004.03.172

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  A CRISPR RNA-binding protein screen reveals regulators of RUNX1 isoform generation.

Authors:  Amanda G Davis; Jaclyn M Einstein; Dinghai Zheng; Nathan D Jayne; Xiang-Dong Fu; Bin Tian; Gene W Yeo; Dong-Er Zhang
Journal:  Blood Adv       Date:  2021-03-09

2.  ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1.

Authors:  G Krapf; U Kaindl; A Kilbey; G Fuka; A Inthal; R Joas; G Mann; J C Neil; O A Haas; E R Panzer-Grümayer
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

3.  Low-level expression of ETV6/TEL in patients with Myelodysplastic syndrome.

Authors:  Tetsuya Yamagata; Yuka Nakamura; Kinuko Mitani
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

4.  Identification of a new site of sumoylation on Tel (ETV6) uncovers a PIAS-dependent mode of regulating Tel function.

Authors:  M Guy Roukens; Mariam Alloul-Ramdhani; Alfred C O Vertegaal; Zeinab Anvarian; Crina I A Balog; André M Deelder; Paul J Hensbergen; David A Baker
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

5.  Downregulation of vertebrate Tel (ETV6) and Drosophila Yan is facilitated by an evolutionarily conserved mechanism of F-box-mediated ubiquitination.

Authors:  M Guy Roukens; Mariam Alloul-Ramdhani; Setareh Moghadasi; Marjolein Op den Brouw; David A Baker
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

6.  Isoform-specific potentiation of stem and progenitor cell engraftment by AML1/RUNX1.

Authors:  Shinobu Tsuzuki; Dengli Hong; Rajeev Gupta; Keitaro Matsuo; Masao Seto; Tariq Enver
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

Review 7.  Understanding small ORF diversity through a comprehensive transcription feature classification.

Authors:  Diego Guerra-Almeida; Diogo Antonio Tschoeke; Rodrigo Nunes-da-Fonseca
Journal:  DNA Res       Date:  2021-09-13       Impact factor: 4.477

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.